{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:22:29Z","timestamp":1791699749237,"version":"4.3.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate the association between a history of acute anterior uveitis (AAU) and the risk of major adverse cardiovascular events (MACE) among patients with ankylosing spondylitis (AS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified 38,691 newly diagnosed AS patients between 2003 and 2013 from the Taiwan National Health Insurance Research Database. The exposure group was defined as people with uveitis diagnosis by ophthalmologist before AS diagnosis date. The incidence of MACE in patients with AS according to the International Classification of Diseases, Ninth Revision. We randomly selected a comparison group without a history of AAU at a 1:4 ratio matched by age, sex, and index year in relation to the risk of developing MACE. We used cox proportional hazard regression model to compare the risk of MACE between groups, shown as adjusted hazard ratios (aHRs) with 95% confidence intervals (CI). Further subgroup analysis and sensitivity tests were also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 3,544 patients in the AAU group and 14,176 patients in the non-AAU group. The aHR of MACE for the AAU group was 0.79 (95% CI = 0.57\u20131.10) at a 1:4 ratio for age, sex and index year. Sensitivity analyses using various adjustment variables showed consistent results. Cox proportional hazard regression model demonstrated that use of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of MACE in this cohort (HR = 3.44; 95% CI = 2.25\u20135.25).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This cohort study showed that subjects with AAU was not associated with the risk of MACE among AS patients, compared to non-AAU controls.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2022.884800","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:57:05Z","timestamp":1657155425000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["The Risk of Major Adverse Cardiovascular Events in Ankylosing Spondylitis Patients With a History of Acute Anterior Uveitis: A Nationwide, Population Based Cohort Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Yi-Chiao","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hsiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui-Ying","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lung","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.29271\/jcpsp.2019.05.418","article-title":"Distribution of HLA-B*27 subtypes in patients with ankylosing spondylitis in local population","volume":"29","author":"Lodhi","year":"2019","journal-title":"J Coll Physicians Surg Pak May."},{"key":"B2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/1756-185X.13487","article-title":"HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a lebanese population: results from a nationwide study","volume":"22","author":"Ziade","year":"2019","journal-title":"Int J Rheum Dis Apr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3899\/jrheum.200188","article-title":"Cardiovascular risk scores in axial spondyloarthritis versus the general population: a cross-sectional study","volume":"48","author":"Liew","year":"2021","journal-title":"J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e3596","DOI":"10.1097\/MD.0000000000003596","article-title":"Midlife ankylosing spondylitis increases the risk of cardiovascular diseases in males 5 years later: a national population-based study","volume":"95","author":"Hung","year":"2016","journal-title":"Medicine."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1874192401509010005","article-title":"Association of high blood pressure with body mass index, smoking and physical activity in healthy young adults","volume":"9","author":"Papathanasiou","year":"2015","journal-title":"Open Cardiovasc Med J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1532832","DOI":"10.1155\/2016\/1532832","article-title":"The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis","volume":"2016","author":"Roshan","year":"2016","journal-title":"Int J Inflam."},{"key":"B8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13075-019-1980-1","article-title":"Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study","volume":"21","author":"Chen","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1167\/iovs.06-0807","article-title":"Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis","volume":"48","author":"Chang","year":"2007","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan's national health insurance research database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/art.39165","article-title":"Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients","volume":"67","author":"Liao","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/1756-185X.13650","article-title":"The risk of herpes zoster among patients with ankylosing spondylitis: a population-based cohort study in Taiwan","volume":"23","author":"Wang","year":"2020","journal-title":"Int J Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/ard.2009.116178","article-title":"Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study","volume":"69","author":"Kang","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.semarthrit.2014.05.017","article-title":"Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study","volume":"44","author":"Berg","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.ophtha.2012.05.026","article-title":"Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study","volume":"119","author":"Hwang","year":"2012","journal-title":"Ophthalmology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity","volume":"100","author":"Kim","year":"2007","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2174\/138161282004140213123505","article-title":"Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review","volume":"20","author":"Armstrong","year":"2014","journal-title":"Curr Pharm Des."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.semarthrit.2020.08.013","article-title":"Microvascular changes of the retina in ankylosing spondylitis, and the association with cardiovascular disease - the eye for a heart study","volume":"50","author":"Van Bentum","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B20","first-page":"3","article-title":"Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis","author":"Ward","year":"1985","journal-title":"J Rheumatol Suppl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/1756-185X.12986","article-title":"Sulfasalazine might reduce risk of cardiovascular diseases in patients with ankylosing spondylitis: A nationwide population-based retrospective cohort study","volume":"20","author":"Tam","year":"2017","journal-title":"Int J Rheum Dis Mar."},{"key":"B22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.26442\/terarkh2018908101-106","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases","volume":"90","author":"Zavodovsky","year":"2018","journal-title":"Ter Arkh."},{"key":"B23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet."},{"key":"B25","first-page":"347","article-title":"Cardiovascular complications of non-steroidal anti-inflammatory drugs","volume":"35","author":"Fosslien","year":"2005","journal-title":"Ann Clin Lab Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"536962","DOI":"10.1155\/2015\/536962","article-title":"NSAIDs and cardiovascular diseases: role of reactive oxygen species","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jama.2020.9151","article-title":"Immortal time bias in observational studies","volume":"325","author":"Yadav","year":"2021","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"De Smet","year":"2011","journal-title":"Prog Retin Eye Res Nov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/09273948.2011.559302","article-title":"An update on the genetics of HLA B27-associated acute anterior uveitis","volume":"19","author":"Martin","year":"2011","journal-title":"Ocul Immunol Inflamm Apr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaophthalmol.2017.1009","article-title":"Association between thyroid disease and uveitis: results from the pacific ocular inflammation study","volume":"135","author":"Borkar","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/1756-185X.14303","article-title":"Prevalence and risk factors for uveitis in spondyloarthritis","volume":"25","author":"Yasmin","year":"2022","journal-title":"Int J Rheum Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.884800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:57:08Z","timestamp":1657155428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.884800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":32,"alternative-id":["10.3389\/fmed.2022.884800"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.884800","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"884800"}}